Your browser doesn't support javascript.
loading
Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial.
Wu, Lindsey; Hsiang, Michelle S; Prach, Lisa M; Schrubbe, Leah; Ntuku, Henry; Dufour, Mi-Suk Kang; Whittemore, Brooke; Scott, Valerie; Yala, Joy; Roberts, Kathryn W; Patterson, Catriona; Biggs, Joseph; Hall, Tom; Tetteh, Kevin K A; Gueye, Cara Smith; Greenhouse, Bryan; Bennett, Adam; Smith, Jennifer L; Katokele, Stark; Uusiku, Petrina; Mumbengegwi, Davis; Gosling, Roly; Drakeley, Chris; Kleinschmidt, Immo.
Affiliation
  • Wu L; London School of Hygiene and Tropical Medicine, Faculty of Infectious Tropical Diseases, Department of Infection Biology, London, United Kingdom of Great Britain.
  • Hsiang MS; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
  • Prach LM; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Schrubbe L; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
  • Ntuku H; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Dufour MK; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Whittemore B; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Scott V; Division of Prevention Science, University of California San Francisco, San Francisco, CA, USA.
  • Yala J; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
  • Roberts KW; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Patterson C; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Biggs J; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Hall T; London School of Hygiene and Tropical Medicine, Faculty of Infectious Tropical Diseases, Department of Infection Biology, London, United Kingdom of Great Britain.
  • Tetteh KKA; London School of Hygiene and Tropical Medicine, Faculty of Infectious Tropical Diseases, Department of Infection Biology, London, United Kingdom of Great Britain.
  • Gueye CS; St. George's University of London, London, UK.
  • Greenhouse B; London School of Hygiene and Tropical Medicine, Faculty of Infectious Tropical Diseases, Department of Infection Biology, London, United Kingdom of Great Britain.
  • Bennett A; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Smith JL; Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Katokele S; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Uusiku P; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
  • Mumbengegwi D; National Vector-Borne Diseases Control Programme, Namibia Ministry of Health and Social Services, Windhoek, Namibia.
  • Gosling R; National Vector-Borne Diseases Control Programme, Namibia Ministry of Health and Social Services, Windhoek, Namibia.
  • Drakeley C; Multidisciplinary Research Centre, University of Namibia, Windhoek, Namibia.
  • Kleinschmidt I; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, United States of America.
EClinicalMedicine ; 44: 101272, 2022 Feb.
Article de En | MEDLINE | ID: mdl-35198913
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Observational_studies / Risk_factors_studies Langue: En Journal: EClinicalMedicine Année: 2022 Type de document: Article Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Observational_studies / Risk_factors_studies Langue: En Journal: EClinicalMedicine Année: 2022 Type de document: Article Pays de publication: Royaume-Uni